Home » Companies » Neuren Pharmaceuticals Limited (Premium)

Neuren Pharmaceuticals Limited (Premium)



Ticker code: NEU

NEU Red Flags & Risk Indicators
⚠️ RED FLAGS: 4 identified

  • Highly Shorted
  • Increasing Shorts
  • High Price to Book vs ROE
  • Falling EBITDA Margins

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
1.64454 0.51696 1.07906 -68.6 108.7 1.35417 0.09691 0.4613 -92.8 376.0
NEU Revenue Per Share (2012–2027)
Neuren Pharmaceuticals Limited (NEU) Revenue Chart 2012–2027
NEU Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
Neuren Pharmaceuticals Limited (NEU) EBITDA Chart 2012–2027
NEU Normalised Earnings Per Share (EPS) (2012–2027)
Neuren Pharmaceuticals Limited (NEU) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
12.6 8.4 18.1 20.0 16.6 145.1 50.0 47.3 4/10/25
NEU Yearly Price Earnings Ratio (PER) Highs and Lows
Neuren Pharmaceuticals Limited (NEU) PER Highs and Lows (2012–2027)
NEU Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Neuren Pharmaceuticals Limited (NEU) 10-Year Weekly ATR Trailing Stop Price Chart


Leave a Reply

Your email address will not be published. Required fields are marked *